Clinical Trial

iCANSleep: Smartphone App-Based Insomnia Treatment for Cancer Survivors

Study acronym: iCANSleep
Recruiting
View on ClinicalTrials.gov →
Summary
The investigators will answer the question of whether treating insomnia using the mobile-app-based intervention of Cognitive Behavioural Therapy for Insomnia (CBT-I) for cancer survivors ("iCANSleep") can improve symptoms of insomnia in Canadian cancer survivors compared to a waitlist control group. The investigators will recruit 146 people with insomnia who have completed cancer treatment at least 3 months prior to the study.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-07-28; most recent amendment 2026-02-18.
Status change: Not Yet Recruiting → Recruiting 2026-02-18
Trial Details
NCT Number NCT07101302
Lead Sponsor Memorial University of Newfoundland
Conditions Insomnia, Cancer
Enrollment 146 participants
Start Date 2025-11-04
Primary Completion 2026-11 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2026-02-20